Wellington Group’s Medtronic MDT Stock Holding History

Wellington Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,556	Closed	-$135K	–	280
2026 Q1	$135K	Sell	1,556 -356	-19%	-$34.1K	0.04%	164
2025 Q4	$184K	Buy	+1,912	New	+$186K	0.06%	148

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wellington Group's MDT Position: Q2 2026 in Review

Wellington Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 1,556 shares — an estimated $135K sold.

Wellington Group first reported a position in MDT in Q4 2025 and held it in 2 quarters. The position peaked at $184K in Q4 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Wellington Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
Wellington Group sold 1,556 Medtronic shares in Q2 2026, an estimated $135K.
Wellington Group first reported a position in Medtronic in Q4 2025 and held it in 2 quarters.
Wellington Group's Medtronic position peaked at $184K in Q4 2025.
2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Wellington Group's 13F filing for Q2 2026, filed 14 Aug 2026.